{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:34:30Z","timestamp":1788910470859,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10549-014-3165-6","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T17:03:50Z","timestamp":1412874230000},"page":"279-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Small molecule 1\u2032-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1\/STAT3\/MMPs signaling pathway"],"prefix":"10.1007","volume":"148","author":[{"given":"Jieqiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"issue":"1","key":"3165_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 64(1):9\u201329","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3165_CR2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127(4):679\u2013695","journal-title":"Cell"},{"issue":"2","key":"3165_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"AJ Redig","year":"2013","unstructured":"Redig AJ, McAllister SS (2013) Breast cancer as a systemic disease: a view of metastasis. J Intern Med 274(2):113\u2013126","journal-title":"J Intern Med"},{"issue":"8","key":"3165_CR4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"PS Steeg","year":"2006","unstructured":"Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12(8):895\u2013904","journal-title":"Nat Med"},{"issue":"1","key":"3165_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","volume":"10","author":"TH Wang","year":"2004","unstructured":"Wang TH, Niu GL, Kortylewski M, Burdelya L, Shain K, Zhang SM, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H (2004) Regulation of the innate and adaptive immune responses by STAT-3 signaling in tumor cells. Nat Med 10(1):48\u201354","journal-title":"Nat Med"},{"issue":"5","key":"3165_CR6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1078-0432.CCR-06-2313","volume":"13","author":"SY Huang","year":"2007","unstructured":"Huang SY (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13(5):1362\u20131366","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3165_CR7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/156652409788488720","volume":"9","author":"E Devarajan","year":"2009","unstructured":"Devarajan E, Huang S (2009) STAT3 as a central regulator of tumor metastases. Curr Mol Med 9(5):626\u2013633","journal-title":"Curr Mol Med"},{"issue":"10","key":"3165_CR8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","volume":"2","author":"JE Darnell Jr","year":"2002","unstructured":"Darnell JE Jr (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2(10):740\u2013749","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"3165_CR9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.onc.1210800","volume":"27","author":"L Knoops","year":"2008","unstructured":"Knoops L, Hornakova T, Royer Y, Constantinescu SN, Renauld JC (2008) JAK kinases overexpression promotes in vitro cell transformation. Oncogene 27(11):1511\u20131519","journal-title":"Oncogene"},{"issue":"12","key":"3165_CR10","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1128\/MCB.16.12.6985","volume":"16","author":"H Jiao","year":"1996","unstructured":"Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T (1996) Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 16(12):6985\u20136992","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3165_CR11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367","journal-title":"Cell"},{"issue":"20","key":"3165_CR12","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1038\/sj.onc.1207383","volume":"23","author":"TX Xie","year":"2004","unstructured":"Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S (2004) STAT3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23(20):3550\u20133560","journal-title":"Oncogene"},{"issue":"29","key":"3165_CR13","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1073\/pnas.0404100101","volume":"101","author":"TN Dechow","year":"2004","unstructured":"Dechow TN, Pedranzini L, Leitch A, Leslie K, Gerald WL, Linkov I, Bromberg JF (2004) Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by STAT3-C. Proc Natl Acad Sci USA 101(29):10602\u201310607","journal-title":"Proc Natl Acad Sci USA"},{"key":"3165_CR14","first-page":"136","volume":"2","author":"KS Siveen","year":"2014","unstructured":"Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BK, Sethi G, Bishayee A (2014) Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta 1845 2:136\u2013154","journal-title":"Biochim Biophys Acta 1845"},{"issue":"2","key":"3165_CR15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.25059","volume":"127","author":"MK Pandey","year":"2010","unstructured":"Pandey MK, Sung B, Aggarwal BB (2010) Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells. Int J Cancer 127(2):282\u2013292","journal-title":"Int J Cancer"},{"issue":"6","key":"3165_CR16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1158\/1078-0432.CCR-10-1123","volume":"17","author":"P Rajendran","year":"2011","unstructured":"Rajendran P, Ong TH, Chen L, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Hui KM, Sethi G (2011) Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin Cancer Res 17(6):1425\u20131439","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3165_CR17","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/carcin\/bgm130","volume":"28","author":"JE Jung","year":"2007","unstructured":"Jung JE, Kim HS, Lee CS, Park DH, Kim YN, Lee MJ, Lee JW, Park JW, Kim MS, Ye SK, Chung MH (2007) Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells. Carcinogenesis 28(8):1780\u20131787","journal-title":"Carcinogenesis"},{"issue":"4","key":"3165_CR18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1349-7006.1996.tb00229.x","volume":"87","author":"M Ohnishi","year":"1996","unstructured":"Ohnishi M, Tanaka T, Makita H, Kawamori T, Mori H, Satoh K, Hara A, Murakami A, Ohigashi H, Koshimizu K (1996) Chemopreventive effect of a xanthine oxidase inhibitor, 1\u2032-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn J Cancer Res 87(4):349\u2013356","journal-title":"Jpn J Cancer Res"},{"issue":"5","key":"3165_CR19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000227593","volume":"53","author":"A Murakami","year":"1996","unstructured":"Murakami A, Ohura S, Nakamura Y, Koshimizu K, Ohigashi H (1996) 1\u2032-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology 53(5):386\u2013391","journal-title":"Oncology"},{"issue":"6","key":"3165_CR20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/carcin\/19.6.1007","volume":"19","author":"T Ohata","year":"1998","unstructured":"Ohata T, Fukuda K, Murakami A, Ohigashi H, Sugimura T, Wakabayashi K (1998) Inhibition by 1\u2032-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells. Carcinogenesis 19(6):1007\u20131012","journal-title":"Carcinogenesis"},{"issue":"9","key":"3165_CR21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1349-7006.1997.tb00457.x","volume":"88","author":"T Tanaka","year":"1997","unstructured":"Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K, Ohigashi H (1997) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1\u2032-acetoxychavicol acetate. Jpn J Cancer Res 88(9):821\u2013830","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"3165_CR22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1349-7006.2000.tb00926.x","volume":"91","author":"K Kawabata","year":"2000","unstructured":"Kawabata K, Tanaka T, Yamamoto T, Ushida J, Hara A, Murakami A, Koshimizu K, Ohigashi H, Stoner GD, Mori H (2000) Suppression of N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis by dietary feeding of 1\u2032-acetoxychavicol acetate. Jpn J Cancer Res 91(2):148\u2013155","journal-title":"Jpn J Cancer Res"},{"key":"3165_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.01.010","volume":"212C","author":"R Kato","year":"2014","unstructured":"Kato R, Matsui-Yuasa I, Azuma H, Kojima-Yuasa A (2014) The synergistic effect of 1\u2032-acetoxychavicol acetate and sodium butyrate on the death of human hepatocellular carcinoma cells. Chem Biol Interact 212C:1\u201310","journal-title":"Chem Biol Interact"},{"issue":"12","key":"3165_CR24","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1271\/bbb.130389","volume":"77","author":"H Wang","year":"2013","unstructured":"Wang H, Shen L, Li X, Sun M (2013) MicroRNAs contribute to the anticancer effect of 1\u2032-acetoxychavicol acetate in human head and neck squamous cell carcinoma cell line HN4. Biosci Biotechnol Biochem 77(12):2348\u20132355","journal-title":"Biosci Biotechnol Biochem"},{"issue":"6","key":"3165_CR25","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3892\/ol.2013.1292","volume":"5","author":"M Williams","year":"2013","unstructured":"Williams M, Tietzel I, Quick QA (2013) 1\u2032-Acetoxychavicol acetate promotes caspase 3-activated glioblastoma cell death by overcoming enhanced cytokine expression. Oncol Lett 5(6):1968\u20131972","journal-title":"Oncol Lett"},{"issue":"2","key":"3165_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0009-2797(01)00301-5","volume":"139","author":"J Moffatt","year":"2002","unstructured":"Moffatt J, Kennedy DO, Kojima A, Hasuma T, Yano Y, Otani S, Murakami A, Koshimizu K, Ohigashi H, Matsui-Yuasa I (2002) Involvement of protein tyrosine phosphorylation and reduction of cellular sulfhydryl groups in cell death induced by 1\u2032-acetoxychavicol acetate in Ehrlich ascites tumor cells. Chem Biol Interact 139(2):215\u2013230","journal-title":"Chem Biol Interact"},{"issue":"10","key":"3165_CR27","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1158\/0008-5472.CAN-05-0072","volume":"65","author":"K Ito","year":"2005","unstructured":"Ito K, Nakazato T, Xian MJ, Yamada T, Hozumi N, Murakami A, Ohigashi H, Ikeda Y, Kizaki M (2005) 1\u2032-acetoxychavicol acetate is a novel nuclear factor kappa B inhibitor with significant activity against multiple myeloma in vitro and in vivo. Cancer Res 65(10):4417\u20134424","journal-title":"Cancer Res"},{"issue":"11","key":"3165_CR28","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.4049\/jimmunol.174.11.7383","volume":"174","author":"H Ichikawa","year":"2005","unstructured":"Ichikawa H, Takada Y, Murakami A, Aggarwal BB (2005) Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J Immunol 174(11):7383\u20137392","journal-title":"J Immunol"},{"issue":"4","key":"3165_CR29","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.bbrc.2005.10.153","volume":"338","author":"K Ito","year":"2005","unstructured":"Ito K, Nakazato T, Murakami A, Ohigashi H, Ikeda Y, Kizaki M (2005) 1\u2032-Acetoxychavicol acetate induces apoptosis of myeloma cells via induction of TRAIL. Biochem Biophys Res Commun 338(4):1702\u20131710","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"3165_CR30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/carcin\/bgr052","volume":"32","author":"X Pang","year":"2011","unstructured":"Pang X, Zhang L, Lai L, Chen J, Wu Y, Yi Z, Zhang J, Qu W, Aggarwal BB, Liu M (2011) 1\u2032-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway. Carcinogenesis 32(6):904\u2013912","journal-title":"Carcinogenesis"},{"issue":"14","key":"3165_CR31","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1158\/0008-5472.CAN-09-0755","volume":"69","author":"X Pang","year":"2009","unstructured":"Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M (2009) Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 69(14):5893\u20135900","journal-title":"Cancer Res"},{"key":"3165_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-4598-9-73","volume":"9","author":"C Li","year":"2010","unstructured":"Li C, Yang Z, Zhai C, Qiu W, Li D, Yi Z, Wang L, Tang J, Qian M, Luo J, Liu M (2010) Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappa B signaling pathway. Mol Cancer 9:73\u201385","journal-title":"Mol Cancer"},{"issue":"2","key":"3165_CR33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1535-7163.MCT-11-0648","volume":"11","author":"J Chen","year":"2012","unstructured":"Chen J, Wang J, Lin L, He L, Wu Y, Zhang L, Yi Z, Chen Y, Pang X, Liu M (2012) Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther 11(2):277\u2013287","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3165_CR34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nprot.2006.69","volume":"1","author":"B Franke-Fayard","year":"2006","unstructured":"Franke-Fayard B, Waters AP, Janse CJ (2006) Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice. Nat Protoc 1(1):476\u2013485","journal-title":"Nat Protoc"},{"issue":"3","key":"3165_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","volume":"84","author":"JN Ihle","year":"1996","unstructured":"Ihle JN (1996) STATs: signal transducers and activators of transcription. Cell 84(3):331\u2013334","journal-title":"Cell"},{"issue":"47","key":"3165_CR36","doi-asserted-by":"crossref","first-page":"45680","DOI":"10.1074\/jbc.M204255200","volume":"277","author":"SJ Schreiner","year":"2002","unstructured":"Schreiner SJ, Schiavone AP, Smithgall TE (2002) Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J Biol Chem 277(47):45680\u201345687","journal-title":"J Biol Chem"},{"issue":"21","key":"3165_CR37","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","volume":"19","author":"T Hirano","year":"2000","unstructured":"Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19(21):2548\u20132556","journal-title":"Oncogene"},{"issue":"7","key":"3165_CR38","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.92.7.3041","volume":"92","author":"HM Seidel","year":"1995","unstructured":"Seidel HM, Milocco LH, Lamb P, Darnell JE Jr, Stein RB, Rosen J (1995) Spacing of palindromic half sites as a determinant of selective signal transducers and activators of transcription (STAT) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92(7):3041\u20133045","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"3165_CR39","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1182\/blood-2006-04-017434","volume":"108","author":"Y Han","year":"2006","unstructured":"Han Y, Amin HM, Franko B, Frantz C, Shi X, Lai R (2006) Loss of SHP1 enhances JAK3\/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK\u00a0+\u00a0anaplastic large-cell lymphoma. Blood 108(8):2796\u20132803","journal-title":"Blood"},{"issue":"1","key":"3165_CR40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/1541-7786.MCR-09-0257","volume":"8","author":"SK Sandur","year":"2010","unstructured":"Sandur SK, Pandey MK, Sung B, Aggarwal BB (2010) 5-hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization. Mol Cancer Res 8(1):107\u2013118","journal-title":"Mol Cancer Res"},{"key":"3165_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00400-1","volume":"306","author":"C Wu","year":"2003","unstructured":"Wu C, Sun M, Liu L, Zhou GW (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306:1\u201312","journal-title":"Gene"},{"issue":"37","key":"3165_CR42","doi-asserted-by":"crossref","first-page":"26656","DOI":"10.1074\/jbc.M705064200","volume":"282","author":"J Zhu","year":"2007","unstructured":"Zhu J, Jia X, Xiao G, Kang Y, Partridge NC, Qin L (2007) EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem 282(37):26656\u201326664","journal-title":"J Biol Chem"},{"issue":"4","key":"3165_CR43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc1837","volume":"6","author":"A Ostman","year":"2006","unstructured":"Ostman A, Hellberg C, Bohmer FD (2006) Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 6(4):307\u2013320","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3165_CR44","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1158\/1078-0432.CCR-06-2575","volume":"13","author":"M Bhutani","year":"2007","unstructured":"Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, Aggarwal BB (2007) Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res 13(10):3024\u20133032","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3165_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-014-2480-2","volume":"74","author":"JC Bendell","year":"2014","unstructured":"Bendell JC, Hong DS, Burris HA 3rd, Naing A, Jones SF, Falchook G, Bricmont P, Elekes A, Rock EP, Kurzrock R (2014) Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors. Cancer Chemother Pharmacol 74(1):125\u2013130","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3165_CR46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","volume":"278","author":"C Gialeli","year":"2011","unstructured":"Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278(1):16\u201327","journal-title":"FEBS J"},{"issue":"3","key":"3165_CR47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8(3):221\u2013233","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"3165_CR48","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","volume":"23","author":"X Lu","year":"2009","unstructured":"Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massague J, Kang Y (2009) ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 23(16):1882\u20131894","journal-title":"Genes Dev"},{"issue":"2","key":"3165_CR49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/01926230490274425","volume":"32","author":"S Orita","year":"2004","unstructured":"Orita S, Hirose M, Takahashi S, Imaida K, Ito N, Shudo K, Ohigashi H, Murakami A, Shirai T (2004) Modifying effects of 1\u2032-acetoxychavicol acetate (ACA) and the novel synthetic retinoids Re-80, Am-580 and Am-55P in a two-stage carcinogenesis model in female rats. Toxicol Pathol 32(2):250\u2013257","journal-title":"Toxicol Pathol"},{"issue":"1","key":"3165_CR50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","volume":"13","author":"BK Park","year":"2007","unstructured":"Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY (2007) NF-kappa B in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13(1):62\u201369","journal-title":"Nat Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3165-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3165-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T19:00:40Z","timestamp":1717441240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3165-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3165-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]}}}